期刊
TOXICOLOGY AND APPLIED PHARMACOLOGY
卷 188, 期 1, 页码 59-68出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/S0041-008X(02)00076-5
关键词
lung disease; cigarette; reactive oxygen; oxidant
资金
- NHLBI NIH HHS [HL49441] Funding Source: Medline
Tobacco smoking has been causally linked to the development of chronic obstructive pulmonary disease. It has been reported that the reactive oxygen species (ROS)-generating enzyme xanthine dehydrogenase/oxidase (XO) is increased in smoking-related stomach ulcers and that gastric mucosal damage caused by tobacco smoke can be blocked by the XO inhibitor allopurinol. In order to test the hypothesis that tobacco may cause the upregulation of XO in the lung, cultured rat pulmonary microvascular endothelial cells were exposed to tobacco smoke condensate (TSC). TSC at a concentration of 20 mug/mL significantly upregulated XO activity after 24 h of exposure. Longer exposure (1 week) to a lower concentration of TSC (2 mug/mL) also caused an increase in XO activity. Unlike hypoxia, TSC treatment did not alter the phosphorylation of XO. However, TSC treatment increased XO mRNA expression and the XO gene promoter activity. Furthermore, actinomycin D blocked the activation of XO by TSC. In conclusion, Our results indicate that tobacco smoke condensate causes upregulation of XO transcription and activity. (C) 2003 Elsevier Science (USA). All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据